Stemline Therapeutics Inc (NASDAQ:STML)

10.05
Delayed Data
As of 4:00pm ET
 -0.15 / -1.47%
Today’s Change
7.82
Today|||52-Week Range
18.22
+5.79%
Year-to-Date
No recent news for Stemline Therapeutics Inc.

Today’s Trading

Previous close10.20
Today’s open10.20
Day’s range9.86 - 10.30
Volume254,148
Average volume (3 months)648,237
Market cap$517.3M
Data as of 4:00pm ET, 12/13/2019

Growth & Valuation

Earnings growth (last year)-1.81%
Earnings growth (this year)+40.76%
Earnings growth (next 5 years)--
Revenue growth (last year)-44.33%
P/E ratioNM
Price/Sales539.39
Price/Book7.81

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc+0.26+2.52%
CRNXCrinetics Pharmaceut...0.000.00%
PRVBProvention Bio Inc+0.53+4.73%
LXRXLexicon Pharmaceutic...-0.21-4.14%
Data as of 4:00pm ET, 12/13/2019

Financials

Next reporting dateMarch 11, 2020
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$500.0K
Annual profit (last year)-$85.0M
Net profit margin-17,004.87%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
New York, New York

Forecasts